Deal History
About us
The Company
Team
Offices
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Newsletter
Contact
Newsletter
INT
DA
DE
FR
SV
US
Main menu button
Team
Deals
Contact
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
26 Feb 2025
Equity Research Immunovia: Making headway with new cancer screening test
Equity Research
Immunovia
25 Feb 2025
Equity research Teneo AI, Q4 2024: Teneo continues to deliver above expectations
Equity Research
Teneo AI
24 Feb 2025
Equity Research ALM Equity, Q4 2024: The market situation is about to improve
Equity Research
ALM Equity
20 Feb 2025
Equity research Viva Wine Group, Q4 2024: Positive growth momentum should continue
Equity Research
Viva Wine Group
20 Feb 2025
Equity Research GIAB: Healthy core business risks reconstruction
Equity Research
GIAB
20 Feb 2025
Equity research Nosa Plugs Q4, 2024: Strong growth and announced M&A strategy
Equity Research
Nosa Plugs
20 Feb 2025
Equity Research ALM Equity, Q4 2024: Stronger finances and an improved market
Equity Research
ALM Equity
20 Feb 2025
Equity research Viva Wine Group, Q4 2024: First impression
Equity Research
Viva Wine Group
17 Feb 2025
Equity Research Ecoclime Q4 2024: Improvement expected in 2025
Equity Research
Ecoclime
17 Feb 2025
Equity Research KlaraBo, Q4 2024: Higher rent increases property value
Equity Research
KlaraBo
16 Feb 2025
Equity research CDON AB, Q4 2024: A mixed bag and room for improvement
Equity Research
CDON
14 Feb 2025
Equity research Zinzino: Significant expansion of US business
Equity Research
Zinzino
14 Feb 2025
Equity Research Ecoclime, Q4 2024: Weak quarter, but expected to improve in 2025
Equity Research
Ecoclime
14 Feb 2025
Equity Research KlaraBo, Q4 2024: Better management results and large property value gains
Equity Research
KlaraBo
14 Feb 2025
Equity Research Nosa Plugs: First impression Q4, 2024
Equity Research
Nosa Plugs
13 Feb 2025
Equity research CDON Q4 2024: First impression
Equity Research
CDON
13 Feb 2025
Equity Research GIAB, Q4 2024: Lack of liquidity due to weak sales
Equity Research
GIAB
11 Feb 2025
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
10 Feb 2025
Equity Research ALM Equity, Q4 2024: Improved outlook for housing development in 2025
Equity Research
ALM Equity
06 Feb 2025
Equity Research GIAB, Q4 2024: Positive impact expected from savings programmes
Equity Research
GIAB
1
2
3
4
5
…
57